##semicolon##
HIV; children; antiretroviral therapy; neurodevelopment; cognitive development; ART timing; Central Asia.##submission.citations##
1. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359(21):2233-2244. doi:10.1056/NEJMoa0800971.
2. Laughton B, Cornell M, Grove D, et al. Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS. 2012;26(13):1685-1690. doi:10.1097/QAD.0b013e328355d0ce.
3. Puthanakit T, Ananworanich J, Vonthanak S, et al. Cognitive function and neurodevelopmental outcomes in HIV-infected children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study. Pediatr Infect Dis J. 2013;32(5):501-508. doi:10.1097/INF.0b013e31827fb19d.
4. Laughton B, Cornell M, Kidd M, et al. Five year neurodevelopment outcomes of perinatally HIV-infected children on early limited or deferred continuous antiretroviral therapy. J Int AIDS Soc. 2018;21(5):e25106. doi:10.1002/jia2.25106.
5. Crowell CS, Malee KM, Yogev R, Muller WJ. Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy. Rev Med Virol. 2014;24(5):316-331. doi:10.1002/rmv. 1793.
6. Sherr L, Croome N, Castaneda KP, Bradshaw K, Romero RH. Developmental challenges in HIV infected children—an updated systematic review. Child Youth Serv Rev. 2014;45:74-89. doi:10. 1016/j.childyouth.2014.03.040.
7. Phillips N, Amos T, Kuo C, et al. HIV-associated cognitive impairment in perinatally infected children: a meta-analysis. Pediatrics. 2016;138(5): e20160893. doi:10.1542/peds.2016-0893.
8. Dahmani S, Rakhmanina N, Jiang X. Cognitive impairment in children and adolescents living with perinatal HIV disease in the ART era: a meta-analysis. EClinicalMedicine. 2024;72:102602. doi:10. 1016/j.eclinm.2024.102602.
9. Horton RH, et al. Neuropsychiatric outcomes in children and adolescents with perinatally acquired HIV: a systematic review and meta-analysis. J Pediatr. 2025.
10. Smith R, Chernoff M, Williams PL, et al. Impact of HIV severity and antiretroviral therapy on neurocognitive outcomes in children with perinatal HIV infection. AIDS. 2012.
11. Williams PL, Marino M, Malee K, et al. Neurocognitive function in children with perinatal HIV infection and long-term antiretroviral exposure.
12. Van Dyke RB, Patel K, Siberry GK, et al. Antiretroviral treatment and neurodevelopmental outcomes in children with perinatal HIV infection.
13. Benki-Nugent S, Tamasha N, Mueni A, Laboso T, Wamalwa D, Njuguna I, Gómez L, Tapia K, Bangirana P, Maleche-Obimbo E, Boivin MJ, John-Stewart G. Early antiretroviral therapy reduces severity but does not eliminate neurodevelopmental compromise in children with HIV. J Acquir Immune Defic Syndr. 2023;93(1):16-24. doi:10.1097/QAI. 0000000000003166.
14. Boivin MJ, Giordani B, Ruiseñor-Escudero H, et al. An academic model for pediatric HIV neurodevelopmental research in sub-Saharan Africa.
15. Puthanakit T, Saphonn V, Ananworanich J, et al. Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis. 2012;12(12):933-941. doi:10.10 16/S1473-3099(12)70242-6.
16. World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization.
17. Panel on Antiretroviral Therapy and Medical Management of Children Living With HIV. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. U.S. Department of Health and Human Services. Updated September 30, 2025.
18. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. doi:10.1136/bmj.n71.
19. Gaparalievich Kozhobekov K, Rahim F, Kalmatov R, Rabiga K. Prevalence, incidence, mortality attributed to HIV in children under 5 years of age, and comparative analysis of health expenditure in central Asian countries. Trends Pediatr. 2025;6(3): 159-172. doi:10.59213/TP.2025.257.
20. UNICEF. HIV statistics: global and regional trends. New York: United Nations Children's Fund; 2021.
21. UNAIDS. The Path That Ends AIDS: 2023 UNAIDS Global AIDS Update. Geneva: Joint United Nations Programme on HIV/AIDS; 2023.
22. Kourtis AP, Lee FK, Abrams EJ, Jamieson DJ, Bulterys M. Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis. 2006;6(11):726-732. doi:10.1016/S1473-3099(06)70629-6.
23. Le Doaré K, Bland R, Newell ML. Neurodevelopment in children born to HIV-infected mothers by infection status. Pediatrics. 2012;130(5):e1326-e1344.
24. Van Rie A, Dow A, Mupambirei Z, et al. Neurodevelopmental outcomes in HIV-infected children and the role of early antiretroviral therapy.
25. Laughton B, Cornell M, Kidd M, et al. Longitudinal neurodevelopmental outcomes of children with perinatally acquired HIV receiving antiretroviral therapy.
26. Ruel TD, Boivin MJ, Boal HE, et al. Neurodevelopmental outcomes in children with HIV and the effects of early treatment.